Inception Return
(2/7/1994)
|
5.77 %
|
|
YTD Return
|
2.89 %
|
|
NAVPS
(6/22/2018)
|
$9.38
|
|
Change
|
($0.01) / -0.13 %
|
|
|
Growth of $10,000
(As of May 31, 2018)
|
|
MER
|
1.89 %
|
|
Assets ($mil)
|
$93.83
|
|
Rank (1Yr)
|
143/153
|
|
Std Dev (3Yr)
|
7.62 %
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Front Fee Only
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
This fund aims to achieve a combination of a high level of income and the potential for capital gains. It invests primarily in higher yielding, lower quality fixed-income securities, preferred stocks and convertible securities issued by U.S. companies.
|
Management Co.
Fidelity Investments Canada ULC
Managers
Harley Lank
|
|
Asset Allocation
(As of March 31, 2018)
|
Sector Allocation
(As of March 31, 2018)
|
Geographic Allocation
(As of March 31, 2018)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| U.S. DOLLAR | Cash and Equivalents | Cash and Cash Equivalent | United States | 0.00% |
| APX Group Inc 8.75% 01-Dec-2020 | Foreign Bonds | Fixed Income | United States | 0.00% |
| INTELSAT TERM B-3 5.71% 27-Nov-2023 | Foreign Bonds | Fixed Income | European Union | 0.00% |
| Valeant Pharmaceutcls Intl Inc 5.88% 15-May-2023 | Foreign Bonds | Fixed Income | United States | 0.00% |
| Ally Financial Inc 8.00% 01-Nov-2031 | Foreign Bonds | Fixed Income | United States | 0.00% |
| Ally Financial Inc 5.75% 20-Nov-2025 | Foreign Bonds | Fixed Income | United States | 0.00% |
| CHS/Community Health Systm Inc 6.25% 31-Mar-2023 | Foreign Bonds | Fixed Income | United States | 0.00% |
| Solera LLC 10.50% 01-Mar-2024 | Foreign Bonds | Fixed Income | United States | 0.00% |
| Citigroup Inc FRN PERP | Foreign Bonds | Fixed Income | United States | 0.00% |
| Chesapeake Energy Corp 8.00% 15-Jun-2027 | Foreign Bonds | Fixed Income | United States | 0.00% |
Performance Data
(As of May 31, 2018)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
1.22
|
1.16
|
0.65
|
2.89
|
-1.87
|
4.64
|
8.05
|
8.98
|
|
Benchmark
|
-0.03
|
-0.23
|
-0.36
|
2.10
|
-1.52
|
6.47
|
9.37
|
10.39
|
|
Quartile Ranking
|
1
|
1
|
1
|
1
|
4
|
1
|
1
|
1
|
|
Calendar Return (%)
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
2010
|
2009
|
2008
|
|
Fund
|
-0.17
|
8.50
|
14.19
|
11.51
|
11.61
|
10.78
|
5.12
|
6.98
|
25.77
|
-3.47
|
|
Benchmark
|
2.96
|
10.80
|
14.93
|
8.91
|
15.20
|
16.66
|
5.18
|
7.95
|
37.56
|
-9.77
|
|
Quartile Ranking
|
4
|
3
|
1
|
1
|
1
|
3
|
1
|
4
|
2
|
1
|
MSCI ESG Fund Metrics (As of June 01, 2018)
|
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.